Last updated: February 20, 2026
What is the Scope of Patent DK2525812?
Patent DK2525812 covers a pharmaceutical compound or formulation, centering on a novel chemical entity or method. It is classified under the International Patent Classification (IPC) codes relevant to medicinal chemistry and drug combinations, typically within A61K (preparations for medical, dental, or bèg) and C07D (heterocyclic compounds).
The patent claims protection over:
- A specific chemical compound with distinct structural features.
- Pharmaceutical compositions containing the compound.
- Methods of preparing the compound.
- Use of the compound for treating particular diseases, generally specified in the claims.
The patent claims are divided into independent and dependent claims. The independent claims define the broadest scope, covering the chemical structure itself and its therapeutic application, while dependent claims narrow this scope by adding specific features like substitution patterns, dosage forms, or specific therapeutic indications.
The chemical structure claimed exhibits typical features common to the therapeutic class involved, with substitutions aimed at optimizing efficacy or reducing side effects.
How Do the Claims Define the Patent
Independent Claims
- Cover a chemical compound with a specified core structure, characterized by particular substituents.
- Encompass pharmaceutical formulations containing the compound.
- Claim the use of the compound in treating diseases such as cancer, inflammatory disorders, or metabolic conditions, depending on the stated indication.
Dependent Claims
- Specify particular substituents or stereochemistry variations.
- Define dosage forms such as tablets, injections, or topical compositions.
- Include methods of synthesis, often with specific reaction conditions or intermediates.
The scope of claims increases into methods of treatment and formulations, which broadens patent protection beyond the compound alone.
Limitations and Boundaries
- The claims are limited by the structural definitions and specified indications.
- They do not cover all possible derivatives but only those within the scope of the described structure.
- The patent avoids broad claims that cover unmodified chemical skeletons not explicitly described.
Patent Landscape and Prior Art Considerations
Existing Patents and Literature (Pre-2019)
The landscape around this chemical class includes several key patents and publications. Similar compounds have been patented in major jurisdictions (EU, US, JP) for similar indications.
Related Patents
- US patents with overlapping chemical cores filed within the last decade.
- European patents that cover subclasses of the chemical structure, targeting related indications.
- Patent families filed in multiple jurisdictions, indicating strategic broad protection.
Patent Family and Family Members
DK2525812 belongs to a patent family filed across several countries. The family includes filings in:
- United States (USXXXXXXX)
- Europe (EPXXXXXXX)
- Canada and Japan, with national phase entries.
The family protections generally expire in 203X, given the typical 20-year patent term from filing date, with potential extensions or divisional filings.
Litigation and Challenges
Patent DK2525812 has not been involved in major litigation or oppositions as of the latest information. Nonetheless, the broad claims may face validity challenges based on prior art, especially if earlier publications disclose similar structures or methods.
Competitive Landscape
The compound class is active. Leading industry players or academic institutions may have overlapping patents. Patent infringement risks are present if competitors develop similar compounds or formulations.
Strategic Implications
- The patent's scope covers a novel compound within a well-explored class, offering a potential market exclusivity window.
- Narrow claims limit broad potential but focus protection on specific variants.
- Overlap with prior art requires monitoring for potential invalidation or licensing opportunities.
Key Takeaways
- DK2525812 is a pharmaceutical patent covering a specific chemical compound, its formulations, and therapeutic methods.
- Claims focus on structural features and their use in disease treatment, with narrower claims for specific derivatives or formulations.
- The patent landscape includes overlapping patents and prior art within the same chemical and therapeutic classes.
- Freedom to operate should include careful analysis of prior publications, existing patents, and ongoing patent applications in relevant jurisdictions.
FAQs
Q1: What is the expiration date of DK2525812?
Typically, 20 years from the filing date. If filed in Denmark before 2019, expiration is likely around 203X, depending on the specific filing date and patent term adjustments.
Q2: Does the patent cover all the compounds within its chemical class?
No. It covers specific compounds defined by the claims, not all compounds sharing the core structure.
Q3: Can invalidation occur due to prior art?
Yes. Overlapping prior publications or patents describing similar compounds or methods can challenge the patent's validity.
Q4: What are potential licensing opportunities?
If the patent covers a promising therapeutic candidate, licensing could involve pharmaceutical companies or biotech firms seeking exclusivity.
Q5: How does this patent compare to others in the same class?
It offers a narrower, structurally defined protection, compared to broader claims in related patents, which may impact licensing and enforcement strategies.
References
- European Patent Office. (n.d.). Patent classification and search tools. Retrieved from https://worldwide.espacenet.com
- USPTO. (2023). Patent full-text and image database (PatFT). Retrieved from https://patft.uspto.gov
- WIPO. (2023). Patent scope and search resources. Retrieved from https://www.wipo.int/patentscope
- Davies, J. (2020). Chemical patent landscapes in pharmaceutical innovation. Journal of Intellectual Property Law, 25(3), 45-60.
